Ardent Health Partners (NYSE:ARDT) Rating Reiterated by Stephens

Ardent Health Partners (NYSE:ARDTGet Free Report)‘s stock had its “overweight” rating reissued by equities researchers at Stephens in a report issued on Thursday, Benzinga reports. They presently have a $24.00 price objective on the stock. Stephens’ price target would indicate a potential upside of 31.29% from the stock’s previous close.

A number of other research firms also recently weighed in on ARDT. Royal Bank of Canada assumed coverage on Ardent Health Partners in a research report on Monday, August 12th. They issued an “outperform” rating and a $23.00 target price for the company. Loop Capital assumed coverage on Ardent Health Partners in a research report on Monday, August 12th. They issued a “buy” rating and a $18.00 target price for the company. Citigroup assumed coverage on Ardent Health Partners in a research report on Monday, August 12th. They issued a “buy” rating and a $21.00 target price for the company. Leerink Partnrs upgraded Ardent Health Partners to a “strong-buy” rating in a research report on Monday, August 12th. Finally, Bank of America assumed coverage on Ardent Health Partners in a research report on Monday, August 12th. They issued a “buy” rating and a $22.00 target price for the company. One investment analyst has rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of $21.70.

Read Our Latest Research Report on Ardent Health Partners

Ardent Health Partners Stock Up 1.7 %

Shares of ARDT opened at $18.28 on Thursday. The firm’s 50-day simple moving average is $17.60. Ardent Health Partners has a 12-month low of $15.00 and a 12-month high of $20.30.

Ardent Health Partners (NYSE:ARDTGet Free Report) last issued its quarterly earnings results on Wednesday, August 14th. The company reported $0.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.30 by $0.05. The business had revenue of $1.47 billion for the quarter, compared to the consensus estimate of $1.46 billion. On average, equities analysts forecast that Ardent Health Partners will post 1.25 earnings per share for the current year.

About Ardent Health Partners

(Get Free Report)

We are the fourth largest privately held, for-profit operator of hospitals and a leading provider of healthcare services in the United States(1). We currently operate in eight growing mid-sized urban markets across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas. We deliver care through a system of 30 acute care hospitals, more than 200 sites of care, and over 1,700 providers that are either employed by or affiliated with us(2), as of March 31, 2024.

Featured Stories

Analyst Recommendations for Ardent Health Partners (NYSE:ARDT)

Receive News & Ratings for Ardent Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.